SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 132 filers reported holding SERES THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,751 | -38.6% | 735,658 | +23.7% | 0.02% | -26.1% |
| Q2 2023 | $2,850 | +1077.7% | 594,895 | +1276.9% | 0.02% | +475.0% |
| Q4 2022 | $242 | -99.6% | 43,204 | +160.3% | 0.00% | +300.0% |
| Q2 2022 | $57,000 | -93.7% | 16,598 | -86.9% | 0.00% | -90.9% |
| Q1 2022 | $904,000 | +23.5% | 126,916 | +44.5% | 0.01% | +37.5% |
| Q4 2021 | $732,000 | -35.9% | 87,825 | +88.4% | 0.01% | -27.3% |
| Q4 2020 | $1,142,000 | – | 46,622 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |